Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Int J Mol Sci. 2022 Jan 2;23(1):495. doi: 10.3390/ijms23010495.
The two β-arrestins (β-arrestin-1 and -2; alternative names: arrestin-2 and -3, respectively) are well known for their ability to inhibit signaling via G protein-coupled receptors. However, β-arrestins can also act as signaling molecules in their own right. Although the two proteins share a high degree of sequence and structural homology, early studies with cultured cells indicated that β-arrestin-1 and -2 are not functionally redundant. Recently, the in vivo metabolic roles of the two β-arrestins have been studied using mutant mice selectively lacking either β-arrestin-1 or -2 in cell types that are of particular relevance for regulating glucose and energy homeostasis. These studies demonstrated that the β-arrestin-1 and -2 mutant mice displayed distinct metabolic phenotypes in vivo, providing further evidence for the functional heterogeneity of these two highly versatile signaling proteins.
两种β-arrestins(β-arrestin-1 和 -2;别名:分别为 arrestin-2 和 -3)以其抑制 G 蛋白偶联受体信号转导的能力而闻名。然而,β-arrestins 本身也可以作为信号分子发挥作用。尽管这两种蛋白质具有高度的序列和结构同源性,但早期对培养细胞的研究表明,β-arrestin-1 和 -2 在功能上并非冗余。最近,使用选择性缺乏细胞类型中β-arrestin-1 或 -2 的突变小鼠,研究了两种β-arrestins 的体内代谢作用,这些细胞类型与调节葡萄糖和能量稳态特别相关。这些研究表明,β-arrestin-1 和 -2 突变小鼠在体内表现出不同的代谢表型,为这两种高度多功能的信号蛋白的功能异质性提供了进一步的证据。